Clinical characteristics and outcome of autoimmune pancreatitis based on serum immunoglobulin G4 level: A single-center, retrospective cohort study
Open Access
- 21 September 2023
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 29 (35) , 5125-5137
Abstract
Pancreatic ductal adenocarcinoma (PDAC) remains a significant public health challenge and is currently the fourth leading cause of cancer-related mortality in developed countries. Despite advances in cancer treatment, the 5-year survival rate for patients with PDAC remains less than 5%. In recent years, neoadjuvant therapy (NAT) has emerged as a promising treatment option for many cancer types, including locally advanced PDAC, with the potential to improve patient outcomes. To analyze the role of NAT in the setting of locally advanced PDAC over the past decade, a systematic literature search was conducted using PubMed and Web of Science. The results suggest that NAT may reduce the local mass size, promote tumor downstaging, and increase the likelihood of resection. These findings are supported by the latest evidence-based medical literature and the clinical experience of our center. Despite the potential benefits of NAT, there are still challenges that need to be addressed. One such challenge is the lack of consensus on the optimal timing and duration of NAT. Improved criteria for patient selection are needed to further identify PDAC patients likely to respond to NAT. In conclusion, NAT has emerged as a promising treatment option for locally advanced PDAC. However, further research is needed to optimize its use and to better understand the role of NAT in the management of this challenging disease. With continued advances in cancer treatment, there is hope of improving the outcomes of patients with PDAC in the future.Keywords
This publication has 51 references indexed in Scilit:
- Recent advances in autoimmune pancreatitis: type 1 and type 2Gut, 2013
- Characteristics of autoimmune pancreatitis based on serum IgG4 levelDigestive and Liver Disease, 2011
- Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroidsJournal of Gastroenterology, 2011
- International Consensus Diagnostic Criteria for Autoimmune PancreatitisPancreas, 2011
- Structure and function of immunoglobulinsJournal of Allergy and Clinical Immunology, 2010
- Standard steroid treatment for autoimmune pancreatitisGut, 2009
- Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalitiesClinical and Experimental Immunology, 2007
- The function of immunoglobulin A in immunityThe Journal of Pathology, 2005
- Defining criteria for autoimmune diseases (Witebsky's postulates revisited)Immunology Today, 1993
- Serum immunoglobulins in calcific pancreatitisGut, 1973